Viewing Study NCT05764720


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-03-11 @ 6:23 AM
Study NCT ID: NCT05764720
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2023-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
Sponsor: Varian, a Siemens Healthineers Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: VAR-2021-07
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View